The historical announcement reported that Lifeint’s platelet RNA sequencing and machine-learning early cancer detection project was selected for a 2018 Xiamen program supporting specialized products and technologies from small businesses.
The announcement described the team’s research focus on platelet RNA analysis for early cancer detection.
Method for isolating highly purified platelets
Platelet RNA sequencing
Deep-learning classifier based on TCP nucleic-acid profiles
The announcement expressed an expectation that the company would develop technical capabilities and clinical recognition over the following one to three years. This was a historical projection, not evidence of achieved clinical performance.
Lifeint provides EV research and application services from sample preparation, isolation and characterization to omics, functional studies, modification and scale-up. It jointly established a biomedical technology centre with Xiamen University School of Pharmaceutical Sciences, built process-development laboratories to GMP standards, and contributed to an EV expert consensus. Its service records cover more than 300 plant species.
Scan to contact us on WeCom
